65,437 trials
Breast Cancer
Primary: Percentage of Participants Who Prematurely Withdrawn From Maintenance Therapy — 93.2; 84.7 percentage of participants
Psoriasis
Primary: Percentage of Subjects With Treatment Success at Day 15 — 30.2; 9.0 percentage of participants
Mild Persistent Asthma
Primary: Baseline Lung Function of Rrs 5 With IOS Before the Bronchodilator (Pre-Rrs5) — 0.73; 0.74; 0.73 kPa/L/s
Cocaine Dependence
Primary: Cocaine Treatment Outcome — 0; 14; 13 positive drug screens
Hypogonadism
Primary: Cmax-am for Oral TU Across Breakfast With Varying Fat Content — 250.7; 334.7; 529.7; 506.0 ng/dL
Prostate Cancer
Primary: Change in Total PSA, Percent Free PSA, and Prostate Volume at 12 Months — -0.75; 1.55; 10.21; 4.89 Relative % difference
Bone Marrow Failure Syndromes · Immunodeficiencies · Immune Dysregulation Syndromes
Primary: Number of Participants With Engraftment — 2 Participants
Cushing's Disease
Primary: Percentage Participants That Attained a mUFC ≤ 1.0 x ULN at Month 7 Regardless of Dose Titration — 41.9; 40.8 percentage of participants
Rheumatoid Arthritis
Primary: Fold Change From Baseline in Varicella Zoster Virus (VZV)-Specific Immunoglobulin G (IgG) Levels at Week 4 — 1.736; 2.105 fold rise
Heart Failure, Diastolic · Obesity
Primary: Exercise Capacity — 15.5; 15.5; 14.1; 16.6 ml/kg/min — p=<0.001
Tardive Dyskinesia
Primary: Change in Total Motor Abnormal Involuntary Movement Scale (AIMS) Score From Baseline to Week 12 Using a Mixed Model For Repeated Measures (MMRM) — -1.4; -2.1; -3.2; -3.3…
Bladder Cancer
Primary: Overall Survival (OS) — 10.6; 11.1; 8.2; 8.9 Months — p=0.4134
Crohn's Disease
Primary: The Number and Percentage of Patients Achieving Clinical Response According to Crohn's Disease Activity Index (CDAI)-70 Criteria at Week 6 — 77; 81 Participants
Bladder Outlet Obstruction
Primary: IPSS Obstructive — 9.1; 7.5; 8.4; 7.9 units on a scale
Coronary Artery Disease
Primary: Number of Participants With Target Lesion Failure at 12 Months Post-Procedure — 5 Participants